Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Our personal experience with intra-aortic balloon pumping

S Skotnicki, J Vincent, A Moulijn

    Acta Chirurgica Belgica
    |July 1, 1978
    PubMed
    Summary

    Intra-aortic balloon pump (IABP) use in 64 patients showed improved hemodynamics in low output syndrome (78%) but low survival rates in cardiogenic shock. Preoperative IABP reduced perioperative myocardial infarction in high-risk ischemic heart disease patients.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Toxicity and Treatment Completion of Neoadjuvant FOLFOXIRI and Chemoradiotherapy in Patients With High-Risk Locally Advanced Rectal Cancer: A Secondary Outcome Analysis of the MEND-IT Trial.

    International journal of radiation oncology, biology, physics·2026
    Same author

    Neoadjuvant FOLFOXIRI prior to chemoradiotherapy for high-risk ("ugly") locally advanced rectal cancer: study protocol of a single-arm, multicentre, open-label, phase II trial (MEND-IT).

    BMC cancer·2022
    Same author

    Steroids in cardiac surgery: a systematic review and meta-analysis.

    British journal of anaesthesia·2018
    Same author

    Combined baseline and one-month changes in big endothelin-1 and brain natriuretic peptide plasma concentrations predict clinical outcomes in patients with left ventricular dysfunction after acute myocardial infarction: Insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) study.

    International journal of cardiology·2017
    Same author

    Histamine in plasma and bronchoalveolar lavage fluid during cardiac surgery: Comparison of a heparin-coated and a non-coated circuit.

    Inflammation research : official journal of the European Histamine Research Society ... [et al.]·2016
    Same author

    Radiobiological evaluation of intensity modulated radiation therapy treatments of patients with head and neck cancer: A dual-institutional study.

    Journal of medical physics·2015

    Area of Science:

    • Cardiology
    • Cardiovascular Surgery
    • Critical Care Medicine

    Background:

    • Intra-aortic counterpulsation (IABP) is a mechanical circulatory support device.
    • Its application is considered in various critical cardiovascular conditions.

    Purpose of the Study:

    • To evaluate the efficacy and outcomes of IABP in patients with low output syndrome, cardiogenic shock, and high-risk ischemic heart disease.

    Main Methods:

    • Retrospective analysis of 64 patients undergoing IABP therapy.
    • Patients were categorized based on the indication for IABP: post-cardiac surgery low output syndrome, refractory cardiogenic shock, and elective preoperative support for ischemic heart disease.

    Main Results:

    • Hemodynamic stabilization was achieved in 78% of patients with low output syndrome, with a 46% survival rate.

    Related Experiment Videos

  • Survival in cardiogenic shock was low (3/13), correlating with shock duration.
  • Elective preoperative IABP in high-risk ischemic heart disease patients resulted in a lower rate of perioperative myocardial infarction.

    • Conclusions:

    • IABP can stabilize hemodynamics in low output syndrome post-cardiac surgery.
    • Outcomes for IABP in cardiogenic shock remain poor and depend on shock duration.
    • Preoperative IABP may reduce perioperative myocardial infarction in selected high-risk ischemic heart disease patients.